Anish Patel - Dec 28, 2023 Form 4 Insider Report for Enliven Therapeutics, Inc. (ELVN)

Role
Chief Operating Officer
Signature
/s/ Ben Hohl, by power of attorney
Stock symbol
ELVN
Transactions as of
Dec 28, 2023
Transactions value $
-$203,348
Form type
4
Date filed
1/2/2024, 08:00 PM
Previous filing
Dec 27, 2023
Next filing
Jan 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELVN Common Stock Sale -$38K -2.52K -7.07% $15.08 33.1K Dec 28, 2023 Direct F1, F2
transaction ELVN Common Stock Sale -$300 -20 -0.06% $15.00 33.1K Dec 29, 2023 Direct F1
transaction ELVN Common Stock Sale -$165K -11K -33.24% $15.00 22.1K Jan 2, 2024 Direct F1, F3
holding ELVN Common Stock 394K Dec 28, 2023 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.
F2 This transaction was executed in multiple trades at prices ranging from $15.00 to $15.28. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 This transaction was executed in multiple trades at prices ranging from $15.00 to $15.005. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 The shares are held by The Patel / Dong Family Trust Dated August 24 2017 for which the Reporting Person serves as trustee.